Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups
Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
10/2008
10/23/2008US20080262070 compounds which mediate the activity of LFA-1 with its ligands involved in cell adhesion, migration and activation.
10/23/2008US20080262058 Inhibitors of HCV replication of formula (I)** Image-1whereinW is a heterocycle of formula** Image-2and the remaining variables are as defined in the specification.
10/23/2008US20080262004 4-[2-(Pyridin-2-yl)-5,6-dihydro-4H-pyrrolo[1,2-b]pyrazol-3-yl]-1H-pyrrolo[2,3-b]pyridine; to treat autoimmune disorders like rheumatoid arthritis, glomerulonephritis, neoplasms; antifibrotic agents
10/23/2008US20080262000 7-amino-5-methoxymethyl-6-octyltriazolo(1,5-a)pyrimidine; activity and/or with a broader activity spectrum
10/23/2008US20080261994 4-[5-((1S,2R)-1-Carboxy-2-phenyl-cyclopropylsulfamoyl)-thiophen-2-yl]-3,6-dihydro-2H-pyridine-1-carboxylic acid tert-butyl ester; aggrecanase and matrix metalloproteinase (with zinc in the catalytic active center) inhibitor; antiarthritic agent: osteoarthritis, rheumatoid arthritis
10/23/2008US20080261988 IMIDAZO[1,2-beta]PYRIDAZINE AND PYRAZOLO[1,5-alpha]PYRIMIDINE DERIVATIVES AND THEIR USE AS PROTEIN KINASE INHIBITORS
10/23/2008US20080261974 Novel Chemical Compounds
10/23/2008US20080261973 Sulphonamidoaniline Derivatives Being Janus Kinase Inhibitors
10/23/2008US20080261971 Novel Heterocyclic Nf-Kb Inhibitors
10/23/2008US20080261970 metabolic syndrome; diabetes; obesity; N-(2-(benzyloxy)-1-(6-methyl-[1,2,4]triazolo[4,3-a]pyridin-3-yl)ethyl)-1-methylpiperidine-4-sulfonamide
10/23/2008US20080261951 Condensed azepines as vasopressin agonists
10/23/2008US20080261950 Drug hybrid of rivastigmine or physostigmine with tranylcypromine, amoxapine, desipramine, nortriptyline, protriptyline, fluoxetine, fluvoxamine, paroxetine, duloxetine, betahistine, amlodipine, proylhexedrine, rimantadine, desloratadine; Alzheimer's disease; Parkinson's disease, impairment in memory
10/23/2008US20080261947 Poly(ADP-ribose)polymerase inhibitor; ischemic diseases, cerebral infarction, antiretroviral, sensitizer for anticancer therapy, immunosuppressant; 5,6,7,8-tetrahydrophthalazin-1(2H)-one compounds; 2,3,4,6-tetrahydropyrido[2,3-d]pyridazin-5(1H)-one compounds
10/23/2008US20080261943 Pyrrolopyrimidine a2b selective antagonist compounds, their synthesis and use
10/23/2008US20080261938 13-Cyclohexyl-5-(2-pyrrolidin-1-ylethoxy)-6,7-dihydro-5H-indolo[2.1-a][2]benzazepine-10-carboxylic acid, for example; use for the treatment or prevention of infection by hepatitis C virus
10/23/2008US20080260685 Prodrugs of cc-1065 analogs
10/23/2008US20080260676 Enhanced solubility in common solvents; ion sensor; removal odors; water and air pollution control
10/23/2008CA2683915A1 Pyrimidinedione derivatives and methods of use thereof
10/23/2008CA2683695A1 3-amido-pyrrolo[3,4-c]pyrazole-5(1h,4h,6h) carbaldehyde derivatives
10/23/2008CA2683619A1 Pharmaceutical compounds
10/23/2008CA2682733A1 Axl kinase inhibitors
10/23/2008CA2670385A1 Folate-conjugates and corresponding metal-chelate complexes for use in diagnostic imaging and radiotherapy
10/22/2008EP1982986A1 Pyrrolopyridazinone compound
10/22/2008EP1981890A2 UNSATURATED mTOR INHIBITORS
10/22/2008EP1981889A1 Cytotoxic agents comprising new tomaymycin derivatives and their therapeutic use
10/22/2008EP1981509A1 Treatment of alzheimer's disease and related conditions
10/22/2008EP1877411A4 Diaryl-purine, azapurines and -deazapurines as non-nucleoside reverse transcriptase inhibitors for treatment of hiv
10/22/2008EP1697359B1 Muscarinic agonists as therapeutic compounds
10/22/2008EP1677599A4 Hydroxy pyridopyrrolopyrazine dione compounds useful as hiv integrase inhibitors
10/22/2008EP1636228B1 Novel pyridopyrazines and use thereof as kinase modulators
10/22/2008EP1549652B1 Fused azole-pyrimidine derivatives
10/22/2008EP1472257B1 Inhibitors of alpha l beta 2 integrin mediated cell adhesion
10/22/2008EP1417190B1 Substituted piperazines as modulators of the melanocortin receptor
10/22/2008CN101291935A Novel imidazoquinazoline derivative, process for preparing the same, and organic electronic device using the same
10/22/2008CN101291934A Crystalline forms of [(1r), 2s]-2-aminopropionic acid 2-[4-(4-fluoro-2-methyl-1h-indol-5-yloxy)-5-methylpyrrolo[2,1-f][1,2,4]triazin-6-yloxy]-1-methylethyl ester
10/22/2008CN101291932A Triazolopyridine derivatives as inhibitors of lipases and phospholipases
10/22/2008CN101289450A Tyrosine phthalocyanines derivates, preparation thereof and applications in preparation of photodynamic drugs
10/22/2008CN100427486C Novel benzimidazole derivatives
10/22/2008CN100427093C 4(2-butylamino)-2,7-dimethyl-8-(2-methyl(-6-methoxyp-3-yl)pyrazolo-[1,5-A]-1,3,5-triazine as corticotropin releasing factor receptor
10/21/2008US7439361 A2a receptor antagonists; Parkinson's disease
10/21/2008US7439345 Supramolecular pairing system, its preparation and use
10/21/2008US7439247 Bicyclic pyridine and pyrimidine P38 kinase inhibitors
10/21/2008US7439240 Reversible inhibitors of cysteine proteases S, K, F, L and B; inhibiting Cathepsin S; analgesics; 1-[9-(4-Chlorophenyl)-2-cyano-9H-purin-6-yl]-L-prolinamide for example
10/21/2008CA2210913C Antipsychotic 4-(1h-indolyl-1-yl)-1-substituted piperidine derivatives
10/16/2008WO2008124848A1 Fused ring heterocycle kinase modulators
10/16/2008WO2008124485A2 Solid forms of pemetrexed
10/16/2008WO2008124083A2 Aurora kinase modulators and method of use
10/16/2008WO2008123685A1 Liposome sensitive to ph or reductive condition and method of preparing the same
10/16/2008WO2008122765A1 New compounds and their uses 707
10/16/2008WO2008122667A2 Ureylene derivatives
10/16/2008WO2008122329A1 Uv-filter compounds
10/16/2008WO2008099416A3 Novel benzothiazole and benzoxazole linked pyrrolo[2,1-c] [1, 4] benzodiazepine hybrids as novel antitumour agents and process for the preparation thereof
10/16/2008WO2008076883A3 Triazine derivatives and their therapeutical applications
10/16/2008WO2007106854A3 Hydroxy and alkoxy substituted 1h-imidazonaphthyridines and methods
10/16/2008US20080255357 Terrylene and Quaterrylene Derivatives
10/16/2008US20080255350 Substituted aza-indoles as inhibitors of poly(adp-ribose) polymerase (parp)
10/16/2008US20080255349 Method for the preparation of an enantiomerically pure benzazepine
10/16/2008US20080255348 converting the carboxylic acid group of 2-(4-methyl-2-phenyl-1-piperazinyl)-3-pyridinecarboxylic acid into a ketone group, then reducing ketone compound with reducing agents to form an intermediate hydroxy group and forming mirtazapine by reduction of hydroxy group; cyclization
10/16/2008US20080255191 Benzylimidazolyl substituted 2-quinoline and quinazoline derivatives for use as farnesyl transferase inhibitors
10/16/2008US20080255183 N-[(3,5-dimethylisoxazol-4-yl)carbonyl]-3-{5-[3-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)propyl]thiophen-2-yl}-L-alanine; treatment of solid tumors
10/16/2008US20080255182 Certain chemical entities, compositions, and methods
10/16/2008US20080255163 Compounds such as 2-piperidino-6-methyl-5-oxo-5,6-dihydro-(7H) pyrrole-[3,4-d]pyrimidine maleate (MS-818); nervous system, brain, and neurodegenerative disorders; Parkinson's, Alzheimer's, and Huntington's disease
10/16/2008US20080255160 Mapk/erk kinase inhibitors
10/16/2008US20080255157 Promoting microtube polymerization; drug resistant cancer; 5-Azepan-1-yl-7-chloro-6-(2,4,6-trifluorophenyl)imidazo[1,2-a]pyrimidine
10/16/2008US20080255156 2-Phenyl-s-triazolo[4,3-c]quinazolin-3-one derivatives; neurodegenerative and central nervous system disorders; Parkinson's and Alzheimer's disease; restless leg syndrome; sleep, attention deficit, and psychological disorders; antidepressants; strokes, psychosis
10/16/2008US20080255154 Cycloalkylcarbonyl-3H-spiro[2-benzofuran-1,3'-pyrrolidin]-3-ones: N-methyl-5-[4-(1-{[3-oxo-1'H,3H-spiro[2-benzofuran-1,3'-pyrrolidin]-1'-yl]carbonyl}cyclopropyl)phenyl]pyridine-2-carboxamide; 11- beta hydroxyl steroid dehydrogenase type 1 inhibitors; mineralcorticoid receptor antagonists; diabetes
10/16/2008US20080255153 New compounds
10/16/2008US20080255146 Macrolide compounds comprising 18,19-epoxytricosa-8,12,14-trien-11-olide derivatives; angiogenesis inhibitors; anticarcinogenic, antimetastasis, antiinflammatory, and antitumor agents; antihypoxic agents; endothelial growth factor suppressors; retinal neovascularization, diabetic retinopathy
10/16/2008US20080255135 1-Aza-bicyclo[2.2.2]octane and 1-aza-bicyclo[2.2.1]heptane derivatives; psychotic, psychological, nervous system and neurodegenerative disorders; nicotinic receptor mediated diseases
10/16/2008US20080255129 3-Heteroaryl-3,5-dihydro-4-oxo-4H-pyridazino[4,5-b]indole-1-acetamide derivatives, their preparation and their application in therapeutics
10/16/2008US20080255110 Imidazoquinoline derivatives as adenosine a3 receptor ligands
10/16/2008US20080255095 Benzylamine analogues
10/16/2008US20080255090 Ceratamines A and B, and Analogues, Syntheses and Pharmaceutical Compositions Thereof
10/16/2008US20080255085 Novel Imidazo [4,5-b] Pyridine Derivatives as Inhibitors of Glycogen Synthase Kinase 3 for Use in the Treatment of Dementia and Neurodegenerative Disorders
10/16/2008US20080253988 Pyrrolo [1,2-D] [1,2-4] Triazine as Inhibitors of C-Jun N Terminal Kinases (Jnk) and P-38 Kinases
10/16/2008CA2683046A1 Non-nucleoside reverse transcriptase inhibitors
10/16/2008CA2681829A1 Solid forms of pemetrexed
10/16/2008CA2681221A1 Isoquinolinone derivatives and their uses
10/15/2008EP1979358A1 Compounds
10/15/2008EP1979357A1 Solid forms of a pyrrolopyrimidine derivative and their use as anti-tumor agents
10/15/2008EP1979356A2 Carbonylamino pyrrolopyrazoles, potent kinase inhibitors
10/15/2008EP1979309A2 Process for the preparation of 6,7-dihydro-5h-imidazo[1,2-a]imidazole-3-sulfonic acid amides and intermediates used therein
10/15/2008EP1978967A1 Quinazolinone derivatives as vanilloid antagonists
10/15/2008EP1802637B1 Cgrp receptor antagonists
10/15/2008EP1776366B1 Immunomodulating oxopyrrazolocinnolines as cd80 inhibitors
10/15/2008EP1742642B1 Phosphonate analogs of hiv integrase inhibitor compounds
10/15/2008EP1544199B1 Nitrogenous condensed-ring compound and use thereof as hiv integrase inhibitor
10/15/2008EP1530572B1 Analogs of indole-3-carbinol metabolites as chemotherapeutic and chemopreventive agents
10/15/2008EP1465617B1 Process for affecting neurologic progression
10/15/2008EP1458723B1 Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function
10/15/2008EP1458722B1 Pyrrolopyrimidines as phosphodiesterase vii inhibitors
10/15/2008EP1383503B1 Use of desoxypeganine for treating central nervous system symptoms resulting from intoxications by psychotrops
10/15/2008EP1375486B1 Nitrogen-containing heteroaryl compounds having hiv integrase inhibitory activity
10/15/2008EP1308439B1 Proline derivatives and use thereof as drugs
10/15/2008EP0363415B1 Compounds for the treatment of alzheimer's disease
10/15/2008CN101287738A Imidazo benzodiazepine derivatives
10/15/2008CN101287737A Pentacyclic kinase inhibitors
10/15/2008CN101287736A Pyrrolopyrimidine derivatives as SYK inhibitors
10/15/2008CN101287468A Methods of making pharmacokinetically improved compounds comprising functional residues or groups and pharmaceutical compositions comprising said compounds
10/15/2008CN100425610C Method for preparing phthalocyanines
1 ... 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 ... 573